Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Endoscopy in Inflammatory Bowel Disease
2007
Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions
2007
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus
2003
The Treatment of Chronic Viral Hepatitis
1997
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
2007
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
2003
A Randomized Controlled Trial of Thymosin–α1 Versus Interferon Alfa Treatment in Patients With Hepatitis B E Antigen Antibody—And Hepatitis B Virus Dna—Positive Chronic Hepatitis B
1996
Review article: hepatitis B and liver transplantation
2006
Long-Term Remission of Chronic Hepatitis B after Alpha-Interferon Therapy
1991
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Recent concepts in non‐alcoholic fatty liver disease
2005
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus
2008
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
2002
Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?
2016
A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis
2008
Hepatocellular carcinoma
2018 Standout
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease
2010
Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon
1992
The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B
2001
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
2002
Ulcerative Colitis
2011 Standout
Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis
2010
Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease
2006
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
2004
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Long–Term Suppression of Hepatitis B E Antigen–Negative Chronic Hepatitis B by 24–Month Interferon Therapy
2003
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
A Randomized, Controlled Study of Thymosin-α1 Therapy in Patients with Anti-HBe, HBV-DNA-Positive Chronic Hepatitis B
2000
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
1998
Autophagy regulates lipid metabolism
2009 StandoutNature
The metabolic syndrome
2010 Standout
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
2009
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
2008
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
1997
Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases
2003
Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review
2006
Hepatitis C virus replication in ‘autoimmune’ chronic hepatitis
1991 StandoutNobel
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
1993 StandoutNature
Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials
1997
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Relation of body mass index to cancer risk in 362,552 Swedish men
2006
Hepatocellular carcinoma
2012 Standout
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
2012
Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin Signaling
2005
Hepatocellular carcinoma
2021 Standout
Chronic hepatitis B
2001
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
2012
Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
2012
Effect of vitamin E on aminotransferase levels and insulin resistance in children with non‐alcoholic fatty liver disease
2006
Natural History of Chronic Hepatitis B Virus Infection: What We Knew in 1981 and What We Know in 2005
2006
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
2011
One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study
2005
Chronic hepatitis D at a standstill: where do we go from here?
2013
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
2004 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis B e antigen-negative chronic hepatitis B
2001
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
2004
Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD
2006
Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents
2008
Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis
2008
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Liver transplantation for chronic viral hepatitis
1995
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
1996
A Randomized Controlled Trial of Lymphoblastoid Interferon–α in Patients With Chronic Hepatitis B Lacking Hbeag
1992
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Independent effects of physical activity in patients with nonalcoholic fatty liver disease #
2009
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
2004
The metabolic syndrome
2005 Standout
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
2006
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
2007
Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study
2010
Prevalence of Transaminase Abnormalities in Asymptomatic, Healthy Subjects Participating in an Executive Health-Screening Program
2003
The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study
2007
Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis
2006
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
2004
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
2009
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents
2008
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B
2000
Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis
2008
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
2015
Chronic hepatitis B
2007 Standout
Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis
2005
Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice
2005
The natural history of chronic hepatitis B virus infection #
2009
Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis B
2001
Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil”
2009
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
2008
Chronic hepatitis B: Update 2009 #
2009 Standout
Dietary Composition and Nonalcoholic Fatty Liver Disease
2004
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease
2005
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease
2006
Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
2016
Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France
1994
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
T-lymphocyte response to hepatitis C virus in different clinical courses of infection
1993 StandoutNobel
Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance
2007
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center
2007
Ulcerative colitis
2016 Standout
Effects of vitamin E treatment on peroxisome proliferator‐activated receptor‐α expression and insulin resistance in patients with non‐alcoholic steatohepatitis: results of a pilot study
2007
Hepatic histology in obese patients undergoing bariatric surgery
2006
Non-alcoholic fatty liver disease: current concepts and management strategies
2006
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
2009
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Bb
1999
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses
2000
The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease
2009
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
Interferon therapy in chronic hepatitis C virus infection
1994
Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
2010
Insulin resistance and C‐reactive protein as independent risk factors for non‐alcoholic fatty liver disease in non‐obese Asian men
2004
Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
2014
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy
2011
Nonalcoholic fatty liver disease and the metabolic syndrome
2005
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
2006
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
2002
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease
2008
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial
1997
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2008
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
2009
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
2000
Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study
2012
Infection in Solid-Organ Transplant Recipients
2007 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
2010
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
2009
Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures
2006
Hepatocellular Carcinoma
2011 Standout
Interferon for non-A, non-B chronic hepatitis
1991
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
2007
Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis
2006
Dietary Habits and Their Relations to Insulin Resistance and Postprandial Lipemia in Nonalcoholic Steatohepatitis
2003
Repeat Endoscopy Affects Patient Management in Pediatric Inflammatory Bowel Disease
2009
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis B
2007
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
2010
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
2013
Hepatocellular carcinoma
2022 Standout
Subtotal Colectomy for Severe Acute Colitis: A 20-Year Experience of a Tertiary Care Center with an Aggressive and Early Surgical Policy
2003
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
2007
Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis
2017
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
2000
Sustained response after a 2‐year course of lamivudine treatment of hepatitis B e antigen‐negative chronic hepatitis B
2004
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Hepatocellular Carcinoma
2019 Standout
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C.
1993 StandoutNobel
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
2008
Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
1998
Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
2004
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C†
1995
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
2008
Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review
2009
Nonalcoholic Fatty Liver Is Not Associated with Carotid Intima-Media Thickness in Type 2 Diabetic Patients
2009
Immunology and the liver
1991
Long term response to therapy of chronic anti-HBe–positive Hepatitis B is poor independent of type and schedule of interferon
1999
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B
1990
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit
2013
Accuracy and the effect of possible subject‐based confounders of magnitude‐based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference
2015
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
2009
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b
1993 StandoutNobel
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
2005
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
2007
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
2007
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
Fatty Liver
2007
Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study
2007
Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis
2016
Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy
2016
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
2007
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.
1991
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
2011
Vitamin E and All-Cause Mortality: A Meta-Analysis
2011
Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease
2009
Works of Ezio David being referenced
Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study
2007
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease
2005
A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis
1990
Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin
2002
Recurrence of hepatitis D (delta) in liver transplants: Histopathological aspects
1993
Hepatitis type C after ortothopic liver transplantation: reinfection and disease recurrence
1994
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
2006
Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
2015
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis
2001
Azathioprine, Mucosal Healing in Ulcerative Colitis, and the Chemoprevention of Colitic Cancer: A Clinical-Practice-Based Forecast
2010
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
2002
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen
1989
Multiparametric Gd-EOB-DTPA magnetic resonance in diagnosis of HCC: dynamic study, hepatobiliary phase, and diffusion-weighted imaging compared to histology after orthotopic liver transplantation
2014
Histologic Changes in Liver Biopsy Specimens Produced by Recombinant Interferon α-2b Therapy for Chronic Non-A,Non-B Viral Hepatitis: A Randomized Controlled Trial
1992
A histological study of hepatitis delta virus liver disease
1986
Colonoscopy in inflammatory bowel disease
1987